Statera Biopharma

+$0.0042 (+1.66%) Today
-$0.0118 (-4.59%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STAB and other ETFs, options, and stocks.

About STAB

Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Its proprietary product toll-like receptor (TLR) agonists in the biopharmaceutical industry with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532 have applications in mitigation of radiation injury and neutropenia an anemia.

CEO
Michael Kevin Handley
Employees
—
Headquarters
Fort Collins, Colorado
Founded
2003

STAB Key Statistics

Market cap
12.99M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.89M
High today
$0.26
Low today
$0.2406
Open price
$0.26
Volume
709.74K
52 Week high
$7.10
52 Week low
$0.2019

STAB Earnings

-$0.47
-$0.31
-$0.16
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure